This is the protocol for a review and there is no abstract. The objectives are as follows:, To evaluate the benefits and harm of different antihypertensive agents in non-diabetic renal disease., To assess the effectiveness of drug classes or combinations of drug classes on the reduction of BP., To assess the relationship between compliance and drug class